Funds and ETFs Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.46 CNY | -0.96% | -0.30% | -10.27% |
05-13 | NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US | MT |
05-01 | NKFPharma Gets Nod to Register New Cancer Treatment | MT |
ETFs positioned on Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.49% | 2 M€ | -12.32% | - | |
0.00% | 2,867 M€ | +10.82% | - | |
0.00% | 454 M€ | +9.19% | - | |
0.00% | 153 M€ | +8.28% | - | |
0.00% | 34 M€ | +4.26% | - | |
0.00% | 7 M€ | +6.24% | - | |
0.00% | 15 M€ | +16.55% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.27% | 3.03B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- 603707 Stock
- Funds and ETFs Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.